AI-native health hardware company Shanmu has secured nearly 100 million yuan in Series A funding, led by Shixi Capital and including participation from existing investors. The company plans to use these funds to launch its direct-to-consumer medical products, fulfill B2B custom module deliveries, and pursue international medical certifications. Shanmu's innovative approach involves embedding medical-grade devices into daily life, such as a toilet-mounted analyzer that continuously collects urine, saliva, and sweat samples for AI-driven health monitoring and intervention. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT This funding round and product development could accelerate the integration of AI-driven continuous health monitoring into daily life, shifting focus from reactive treatment to proactive health management.
RANK_REASON AI-native health hardware company Shanmu secured nearly 100 million yuan in Series A funding. [lever_c_demoted from significant: ic=1 ai=0.7]
